Artificial Contrast: Deep Learning for Reducing Gadolinium-Based Contrast Agents in Neuroradiology

Area of Science:

• Neuroradiology
• Medical Imaging
• Artificial Intelligence

Background:

• Deep learning is increasingly vital in diagnostic medicine, particularly neuroradiology.
• Concerns regarding gadolinium deposition necessitate reduced use of contrast agents.
• Reevaluation of gadolinium-based contrast agent administration is ongoing.

Purpose of the Study:

• To review deep learning applications for reducing gadolinium contrast agents in medical imaging.
• To discuss the advantages and limitations of deep learning in low-dose and zero-dose contrast agent approaches.
• To assess the clinical applicability and challenges of these AI-driven methods.

Main Methods:

• Review of recent studies employing deep learning for contrast agent reduction.
• Analysis of deep learning techniques for low-dose and zero-dose contrast agent strategies.
• Evaluation of challenges in assessing deep learning model outputs.

Main Results:

• Deep learning enables significant reduction or elimination of gadolinium contrast agents.
• Various deep learning methods show promise in diverse patient populations.
• Progress is being made toward clinical integration of these AI approaches.

Conclusions:

• Deep learning offers a viable path to minimize gadolinium contrast agent use in neuroradiology.
• Further research is needed to address challenges in output assessment and clinical validation.
• AI-driven strategies hold potential for safer medical imaging practices.